MUSCARINIC ACETYLCHOLINE-RECEPTORS IN THE SINOATRIAL NODE AND RIGHT ATRIUM OF BOVINE HEART

被引:3
作者
BRAUN, AP [1 ]
PHAN, TD [1 ]
SULAKHE, PV [1 ]
机构
[1] UNIV SASKATCHEWAN,COLL MED,DEPT PHYSIOL,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1990年 / 189卷 / 2-3期
关键词
MUSCARINIC ACETYLCHOLINE RECEPTORS; SINOATRIAL NODE; ATRIUM; GUANINE NUCLEOTIDES; PHOSPHOLIPASE; N-ETHYLMALEIMIDE;
D O I
10.1016/0922-4106(90)90024-R
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Muscarinic acetylcholine receptors were identified by the specific binding of [H](-)quinuclidinylbenzilate ([H-3](-)QNB) and [H-3]oxotremorine-M ([H-3]Oxo-M), to membranes isolated from the sino-atrial (SA) node and right atrium (RA) of bovine heart. The density of [H-3](-)QNB binding sites was greater in the SA node compared to the RA. Specific [H-3](-)QNB binding was saturable and occurred to a single population of binding sites in both regions. The binding of antagonists, as assessed by competition with [H-3](-)QNB, also occurred to a single population of sites; the binding affinities of all antagonists were similar in either region. Agonist competition curves, except for McN-A-343, were complex and computer analyses indicated that agonists bound to at least two populations of binding sites that differed in affinity. The proportion of high-affinity agonist binding sites was consistently greater in the SA nodal, relative to the RA membranes, while the affinity of the high-affinity agonist binding sites to a given agonist was essentially similar in either region. The high-affinity binding of [H-3]Oxo-M was saturable and occurred to a single population of sites. The maximal binding of [H-3]Oxo-M in the SA nodal membranes was higher than in the RA membranes. Guanine nucleotides and N-ethylmaleimide (NEM) markedly decreased [H-3]Oxo-M binding; NEM did not appear to influence guanine nucleotide-dependent decrease in [H-3]Oxo-M binding. Phospholipase A2 decreased both [H-3](-)QNB and [H-3]Oxo-M specific binding, the latter being affected to a greater extent. Phospholipase C also decreased [H-3](-)QNB and [H-3]Oxo-M binding, although to a lesser degree compared to phospholipase A2. Either lipase, however, increased the guanine nucleotide-sensitive agonist binding. Analysis of [H-3](-)QNB binding to microsomal subfractions showed that binding sites were enriched in the light plasma membrane fractions that were also enriched in pertussis toxin sensitive guanine nucleotide binding proteins.
引用
收藏
页码:201 / 215
页数:15
相关论文
共 50 条
[1]   ROLE OF PHOSPHOLIPIDS IN MUSCARINIC BINDING BY NEURAL MEMBRANES [J].
ARONSTAM, RS ;
ABOOD, LG ;
BAUMGOLD, J .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (18) :1689-1695
[2]   GUANINE-NUCLEOTIDES MODULATE MUSCARINIC RECEPTOR-BINDING IN THE HEART [J].
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 87 (04) :1000-1005
[3]   AGONIST AND ANTAGONIST BINDING OF MUSCARINIC ACETYLCHOLINE-RECEPTORS PURIFIED FROM PORCINE BRAIN - INTERCONVERSION OF HIGH-AFFINITY AND LOW-AFFINITY SITES BY SULFHYDRYL-REAGENTS [J].
BERSTEIN, G ;
HAGA, K ;
HAGA, T ;
ICHIYAMA, A .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (06) :1687-1694
[4]   THE BINDING OF PIRENZEPINE TO DIGITONIN-SOLUBILIZED MUSCARINIC ACETYLCHOLINE-RECEPTORS FROM THE RAT MYOCARDIUM [J].
BIRDSALL, NJM ;
HULME, EC ;
KEEN, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (02) :307-316
[5]   THE MOLECULAR-BASIS OF MUSCARINIC RECEPTOR DIVERSITY [J].
BONNER, TI .
TRENDS IN NEUROSCIENCES, 1989, 12 (04) :148-151
[6]   ATTENUATION BY N-ETHYLMALEIMIDE TREATMENT OF THE CHOLINERGICALLY INDUCED SHORTENING OF ACTION-POTENTIAL DURATION IN GUINEA-PIG RIGHT ATRIUM [J].
BRAUN, AP ;
SPERELAKIS, N .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (23) :4577-4581
[7]  
BRAUN AP, 1986, NEUROMETHODS, V4, P139
[8]  
BRAUN AP, 1990, IN PRESS EUROPEAN J, V189
[9]  
CASEY PJ, 1988, J BIOL CHEM, V263, P2577
[10]   DISCRIMINATION BY N-ETHYLMALEIMIDE BETWEEN THE CHRONOTROPIC AND INOTROPIC RESPONSE TO MUSCARINIC RECEPTOR STIMULATION IN RAT ATRIUM [J].
DOODS, HN ;
DAVIDESKO, D ;
MATHY, MJ ;
BATINK, HD ;
DEJONGE, A ;
VANZWIETEN, PA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (02) :182-185